首页> 美国卫生研究院文献>Case Reports in Neurological Medicine >Is Intravenous Heparin a Contraindication for TPA in Ischemic Stroke?
【2h】

Is Intravenous Heparin a Contraindication for TPA in Ischemic Stroke?

机译:静脉肝素是否可作为缺血性卒中TPA的禁忌症?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

There are approximately 2 million cardiac catheterizations that occur every year in the United States and with an aging population this number continues to rise. Adverse events due to this procedure occur at low rates and include stroke, arrhythmia, and myocardial infarctions. Due to the high volume of procedures there are a growing number of adverse events. Stroke after cardiac catheterization (SCC) has an incidence between 0.27 and 0.5% and is one of the most debilitating complications leading to high rates of mortality and morbidity. Given the relatively uncommon clinical setting of stroke after cardiac catheterization, treatment protocols regarding the use of IV or IA thrombolysis have not been adequately developed. Herein, we describe a case of a 39-year-old male who developed a stroke following a cardiac catheterization where IV thrombolysis was utilized although the patient was on heparin prior to cardiac catheterization.
机译:在美国,每年大约发生200万例心脏导管插入术,并且随着人口老龄化,这个数字还在继续增加。由该程序引起的不良事件发生率低,包括中风,心律不齐和心肌梗塞。由于手术量大,不良事件越来越多。心脏导管插入术(SCC)后中风的发生率在0.27%至0.5%之间,是最令人衰弱的并发症之一,导致高死亡率和高发病率。考虑到心脏导管插入术后卒中的临床情况相对罕见,有关使用IV或IA溶栓治疗的治疗方案尚未得到充分开发。本文中,我们描述了一个39岁的男性,该患者在进行心脏导管插入术后发生了中风,尽管患者在进行心脏导管插入术之前使用了肝素,但仍使用IV溶栓治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号